December 18 is National Multiple Sclerosis Day. To commemorate it, Fundación Merck Salud awards the Multiple Sclerosis Solidarity Awards, which this year reach their fifth edition. On this occasion, the recognitions, which have the social support of the Spanish Neurology Society, have been announced within the framework of EFE Health Forum. Among the winners, this year are Dr. Manuel Comabella, from the Clinical Neuroimmunology Service at the Vall d’Hebron University Hospital, head of the Clinical Neuroimmunology laboratory at the Vall d’Hebron Research Institute (VHIR) and head of laboratory at the Multiple Sclerosis Centre of Catalonia (Cemcat); and Dr. Sunny Malhotra, researcher at the Clinical Neuroimmunology group at VHIR and Cemcat.
The MS Solidarity Awards are aimed at the ideas, people or projects that have been the most valued or recognized within the world of multiple sclerosis nationally this year. The awards have two categories, collective and individual, being in the latter where the Vall d’Hebron researchers have received recognition as professionals who, with their efforts, work to help people with multiple sclerosis.
Specifically, researchers have been awarded for their research, which aims to identify prognostic biomarkers for multiple sclerosis with the potential to become therapeutic targets. Among them, they have identified two factors (IL1B and NLRP3) in patients with primary progressive multiple sclerosis, a clinical form with a greater degenerative component for which the therapeutic arsenal is currently limited.